1)- Cristina de Dios, Xenia Abadin, Vicente Roca-Agujetas, Marina Jimenez-Martinez, Albert Morales, Ramon Trullas, Montserrat Mari, Anna Colell. Inflammasome activation under high cholesterol load triggers a protective microglial phenotype while promoting neuronal pyroptosis.Translational neurodegeneration. 2023, 12 (1): 10
2)- Sarawoot Somin, Don Kulasiri, Sandhya Samarasinghe. Alleviating the unwanted effects of oxidative stress on Aβ clearance: a review of related concepts and strategies for the development of computational modelling.Translational neurodegeneration. 2023, 12 (1): 11
3)- Matthias Schmitz, Niccolò Candelise, Sezgi Canaslan, Hermann C Altmeppen, Jakob Matschke, Markus Glatzel, Neelam Younas, Saima Zafar, Peter Hermann, Inga Zerr. α-Synuclein conformers reveal link to clinical heterogeneity of α-synucleinopathies.Translational neurodegeneration. 2023, 12 (1): 12
5)- Hash Brown Taha, Simon Hornung, Suman Dutta, Leony Fenwick, Otmane Lahgui, Kathryn Howe, Nour Elabed, Irish Del Rosario, Darice Y Wong, Aline Duarte Folle, Daniela Markovic, Jose-Alberto Palma, Un Jung Kang, Roy N Alcalay, Miriam Sklerov, Horacio Kaufmann, Brent L Fogel, Jeff M Bronstein, Beate Ritz, Gal Bitan. Toward a biomarker panel measured in CNS-originating extracellular vesicles for improved differential diagnosis of Parkinson's disease and multiple system atrophy.Translational neurodegeneration. 2023, 12 (1): 14
6)- Anouk Tosserams, Bastiaan R Bloem, Kaylena A Ehgoetz Martens, Rick C Helmich, Roy P C Kessels, James M Shine, Natasha L Taylor, Gabriel Wainstein, Simon J G Lewis, Jorik Nonnekes. Modulating arousal to overcome gait impairments in Parkinson's disease: how the noradrenergic system may act as a double-edged sword.Translational neurodegeneration. 2023, 12 (1): 15
7)- Koji Yoshida, Yukiko Hata, Shojiro Ichimata, Keitaro Okada, Naoki Nishida. Argyrophilic grain disease is common in older adults and may be a risk factor for suicide: a study of Japanese forensic autopsy cases.Translational neurodegeneration. 2023, 12 (1): 16
9)- Sina Shadfar, Sonam Parakh, Md Shafi Jamali, Julie D Atkin. Redox dysregulation as a driver for DNA damage and its relationship to neurodegenerative diseases.Translational neurodegeneration. 2023, 12 (1): 18
12)- Nuole Zhu, Miguel Santos-Santos, Ignacio Illán-Gala, Victor Montal, Teresa Estellés, Isabel Barroeta, Miren Altuna, Javier Arranz, Laia Muñoz, Olivia Belbin, Isabel Sala, Maria Belén Sánchez-Saudinós, Andrea Subirana, Laura Videla, Jordi Pegueroles, Rafael Blesa, Jordi Clarimón, Maria Carmona-Iragui, Juan Fortea, Alberto Lleó, Daniel Alcolea. Correction: Plasma glial fibrillary acidic protein and neurofilament light chain for the diagnostic and prognostic evaluation of frontotemporal dementia.Translational neurodegeneration. 2023, 12 (1): 21
15)- Kelsie M LaBarbera, Yvette I Sheline, Nicholas J Izzo, Carla M Yuede, Lora Waybright, Raymond Yurko, Hannah M Edwards, Woodrow D Gardiner, Kaj Blennow, Henrik Zetterberg, Anne Börjesson-Hanson, Roger Morgan, Charles S Davis, Robert J Guttendorf, Lon S Schneider, Steven DeKosky, Harry LeVine, Michael Grundman, Anthony O Caggiano, John R Cirrito, Susan M Catalano, Mary E Hamby. A phase 1b randomized clinical trial of CT1812 to measure Aβ oligomer displacement in Alzheimer's disease using an indwelling CSF catheter.Translational neurodegeneration. 2023, 12 (1): 24
16)- Zhihai Huang, J Dedrick Jordan, Quanguang Zhang. Early life adversity as a risk factor for cognitive impairment and Alzheimer's disease.Translational neurodegeneration. 2023, 12 (1): 25
17)- Katherine E Olson, Mai M Abdelmoaty, Krista L Namminga, Yaman Lu, Helen Obaro, Pamela Santamaria, R Lee Mosley, Howard E Gendelman. An open-label multiyear study of sargramostim-treated Parkinson's disease patients examining drug safety, tolerability, and immune biomarkers from limited case numbers.Translational neurodegeneration. 2023, 12 (1): 26
21)- Xiao-Yan Li, Juan-Juan Xie, Jin-Hong Wang, Yu-Feng Bao, Yi Dong, Bin Gao, Ting Shen, Pei-Yu Huang, Hao-Chao Ying, Han Xu, Anna Wang Roe, Hsin-Yi Lai, Zhi-Ying Wu. Perivascular spaces relate to the course and cognition of Huntington's disease.Translational neurodegeneration. 2023, 12 (1): 30
22)- Alice Drobny, Fanni Annamária Boros, Denise Balta, Susy Prieto Huarcaya, Deniz Caylioglu, Niyeti Qazi, Julia Vandrey, Yanni Schneider, Jan Philipp Dobert, Caleb Pitcairn, Joseph Robert Mazzulli, Friederike Zunke. Reciprocal effects of alpha-synuclein aggregation and lysosomal homeostasis in synucleinopathy models.Translational neurodegeneration. 2023, 12 (1): 31
26)- Cristiano D'Andrea, Federico Angelo Cazzaniga, Edoardo Bistaffa, Andrea Barucci, Marella de Angelis, Martina Banchelli, Edoardo Farnesi, Panagis Polykretis, Chiara Marzi, Antonio Indaco, Pietro Tiraboschi, Giorgio Giaccone, Paolo Matteini, Fabio Moda. Impact of seed amplification assay and surface-enhanced Raman spectroscopy combined approach on the clinical diagnosis of Alzheimer's disease.Translational neurodegeneration. 2023, 12 (1): 35
27)- Axelle Dovonou, Cyril Bolduc, Victoria Soto Linan, Charles Gora, Modesto R Peralta Iii, Martin Lévesque. Animal models of Parkinson's disease: bridging the gap between disease hallmarks and research questions.Translational neurodegeneration. 2023, 12 (1): 36
28)- Celso S G Catumbela, Vijayasree V Giridharan, Tatiana Barichello, Rodrigo Morales. Clinical evidence of human pathogens implicated in Alzheimer's disease pathology and the therapeutic efficacy of antimicrobials: an overview.Translational neurodegeneration. 2023, 12 (1): 37
29)- Linlin Wan, Sudan Zhu, Zhao Chen, Rong Qiu, Beisha Tang, Hong Jiang. Multidimensional biomarkers for multiple system atrophy: an update and future directions.Translational neurodegeneration. 2023, 12 (1): 38
32)- Linn Oftedal, Johannes Lange, Kenn Freddy Pedersen, Aleksander Hagen Erga, Ingvild Dalen, Ole-Bjørn Tysnes, Guido Alves, Jodi Maple-Grødem. Early GCase activity is a predictor of long-term cognitive decline in Parkinson's disease.Translational neurodegeneration. 2023, 12 (1): 41
33)- Wojciech Paslawski, Shervin Khosousi, Ellen Hertz, Ioanna Markaki, Adam Boxer, Per Svenningsson. Large-scale proximity extension assay reveals CSF midkine and DOPA decarboxylase as supportive diagnostic biomarkers for Parkinson's disease.Translational neurodegeneration. 2023, 12 (1): 42
35)- Zhi Dong Zhou, Ling Xiao Yi, Dennis Qing Wang, Tit Meng Lim, Eng King Tan. Role of dopamine in the pathophysiology of Parkinson's disease.Translational neurodegeneration. 2023, 12 (1): 44
36)- Saumya Maheshwari, Gabriela Vilema-Enríquez, Richard Wade-Martins. Patient-derived iPSC models of Friedreich ataxia: a new frontier for understanding disease mechanisms and therapeutic application.Translational neurodegeneration. 2023, 12 (1): 45
38)- Peter J Richardson, Daniel P Smith, Alex de Giorgio, Xenia Snetkov, Joshua Almond-Thynne, Sara Cronin, Richard J Mead, Christopher J McDermott, Pamela J Shaw. Janus kinase inhibitors are potential therapeutics for amyotrophic lateral sclerosis.Translational neurodegeneration. 2023, 12 (1): 47
40)- Yi Xu, Yanling Yang, Xi Chen, Danling Jiang, Fei Zhang, Yao Guo, Bin Hu, Guohai Xu, Shengliang Peng, Lidong Wu, Jialing Hu. NLRP3 inflammasome in cognitive impairment and pharmacological properties of its inhibitors.Translational neurodegeneration. 2023, 12 (1): 49
41)- Hyunkyung Mo, Juryun Kim, Jennifer Yejean Kim, Jang Woon Kim, Heeju Han, Si Hwa Choi, Yeri Alice Rim, Ji Hyeon Ju. Intranasal administration of induced pluripotent stem cell-derived cortical neural stem cell-secretome as a treatment option for Alzheimer's disease.Translational neurodegeneration. 2023, 12 (1): 50
42)- Yang Gao, Yuying Wang, Huiyang Lei, Zhendong Xu, Shihong Li, Haitao Yu, Jiazhao Xie, Zhentao Zhang, Gongping Liu, Yao Zhang, Jie Zheng, Jian-Zhi Wang. A novel transgenic mouse line with hippocampus-dominant and inducible expression of truncated human tau.Translational neurodegeneration. 2023, 12 (1): 51
45)- Alireza Faridar, Abdulmunaim M Eid, Aaron D Thome, Weihua Zhao, David R Beers, Maria B Pascual, Mohammad O Nakawah, Gustavo C Roman, Charles S Davis, Michael Grundman, Joseph C Masdeu, Stanley H Appel. A phase 1 open-label pilot study of low-dose interleukine-2 immunotherapy in patients with Alzheimer's disease.Translational neurodegeneration. 2023, 12 (1): 54
46)- Wenying Xu, Jie Wang, Xin-Ni Li, Jingxue Liang, Lu Song, Yi Wu, Zhenguo Liu, Bomin Sun, Wei-Guang Li. Neuronal and synaptic adaptations underlying the benefits of deep brain stimulation for Parkinson's disease.Translational neurodegeneration. 2023, 12 (1): 55
47)- Carolyn Tallon, Benjamin J Bell, Medhinee M Malvankar, Pragney Deme, Carlos Nogueras-Ortiz, Erden Eren, Ajit G Thomas, Kristen R Hollinger, Arindom Pal, Maja Mustapic, Meixiang Huang, Kaleem Coleman, Tawnjerae R Joe, Rana Rais, Norman J Haughey, Dimitrios Kapogiannis, Barbara S Slusher. Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in an Alzheimer's disease mouse model.Translational neurodegeneration. 2023, 12 (1): 56
48)- Ting Shen, Jacob W Vogel, Jeffrey Duda, Jeffrey S Phillips, Philip A Cook, James Gee, Lauren Elman, Colin Quinn, Defne A Amado, Michael Baer, Lauren Massimo, Murray Grossman, David J Irwin, Corey T McMillan. Novel data-driven subtypes and stages of brain atrophy in the ALS-FTD spectrum.Translational neurodegeneration. 2023, 12 (1): 57
50)- Xuxiang Zhang, Beisha Tang, Jifeng Guo. Parkinson's disease and gut microbiota: from clinical to mechanistic and therapeutic studies.Translational neurodegeneration. 2023, 12 (1): 59